The intermediate-conductance calcium-activated potassium channel KCa3.1 contributes to atherogenesis in mice and humans
- 2 September 2008
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 118 (9), 3025-3037
- https://doi.org/10.1172/jci30836
Abstract
Atherosclerosis remains a major cause of death in the developed world despite the success of therapies that lower cholesterol and BP. The intermediate-conductance calcium-activated potassium channel KCa3.1 is expressed in multiple cell types implicated in atherogenesis, and pharmacological blockade of this channel inhibits VSMC and lymphocyte activation in rats and mice. We found that coronary vessels from patients with coronary artery disease expressed elevated levels of KCa3.1. In Apoe–/– mice, a genetic model of atherosclerosis, KCa3.1 expression was elevated in the VSMCs, macrophages, and T lymphocytes that infiltrated atherosclerotic lesions. Selective pharmacological blockade and gene silencing of KCa3.1 suppressed proliferation, migration, and oxidative stress of human VSMCs. Furthermore, VSMC proliferation and macrophage activation were reduced in KCa3.1–/– mice. In vivo therapy with 2 KCa3.1 blockers, TRAM-34 and clotrimazole, significantly reduced the development of atherosclerosis in aortas of Apoe–/– mice by suppressing VSMC proliferation and migration into plaques, decreasing infiltration of plaques by macrophages and T lymphocytes, and reducing oxidative stress. Therapeutic concentrations of TRAM-34 in mice caused no discernible toxicity after repeated dosing and did not compromise the immune response to influenza virus. These data suggest that KCa3.1 blockers represent a promising therapeutic strategy for atherosclerosis.Keywords
This publication has 66 references indexed in Scilit:
- Efficacy and safety of the Gardos channel blocker, senicapoc (ICA-17043), in patients with sickle cell anemiaBlood, 2008
- Hydrogen Peroxide Inhibits Cytochrome P450 EpoxygenasesCirculation Research, 2008
- Macrophage-specific transgenic expression of cholesteryl ester hydrolase significantly reduces atherosclerosis and lesion necrosis in Ldlr–/– miceJCI Insight, 2007
- The Ca2+-activated K+channel KCa3.1 compartmentalizes in the immunological synapse of human T lymphocytesAmerican Journal of Physiology-Cell Physiology, 2007
- Functional KCa3.1 K+ channels are required for human lung mast cell migrationThorax, 2006
- Recent advances in Ca2+-dependent Ras regulation and cell proliferationCell Calcium, 2006
- Blockade of the Intermediate-Conductance Calcium-Activated Potassium Channel as a New Therapeutic Strategy for RestenosisCirculation, 2003
- Phenotype modulation in cultures of vascular smooth muscle cells from diabetic rats: Association with increased nitric oxide synthase expression and superoxide anion generationJournal of Cellular Physiology, 2003
- Inflammation in atherosclerosisNature, 2002
- Interferon-γ-induced apoptosis and activation of THP-1 macrophagesLife Sciences, 2002